Clinical Trials Browser

Interventional × lutetium Lu 177 dotatate × Thoracic × Clear all

NCT05142696 2026-03-17

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Phase 1/2 Active not recruiting

Extensive Stage Small Cell Lung Cancer

NCT03325816 2021-03-16

Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer

Phase 1/2 Completed

9 enrolled 10 charts

Small Cell Lung Carcinoma